Originality

AmpliTech Group Unveils AGTGSS Flagship Product, A Massive MIMO, 64T64R ORAN, CAT B Radio And Launches New AGTGSS Division Website

Retrieved on: 
Wednesday, January 10, 2024
OEM, RAN, Originality, Radio, Massive, Original equipment manufacturer, MIMO, SRS, CAT, Catalog, Interface

AmpliTech Group's AGTGSS division stands at the forefront of cutting-edge telecommunications technology as a distinguished Original Equipment Manufacturer (OEM) specializing in 5G solutions.

Key Points: 
  • AmpliTech Group's AGTGSS division stands at the forefront of cutting-edge telecommunications technology as a distinguished Original Equipment Manufacturer (OEM) specializing in 5G solutions.
  • With a relentless commitment to innovation, AmpliTech has established itself as a trailblazer in the rapidly evolving landscape of fifth-generation wireless technology.
  • The Massive MIMO, 64T64R ORAN, CAT B Radio Network is expected to become the company’s flagship product.
  • From providing a wide array of 4G/True 5G radio networks choices (RAN & ORAN) to full-service provider including on-site radio networks installations and cloud management.

OP[4] Launches Advanced Platform for Automated Product Security

Retrieved on: 
Wednesday, January 10, 2024
24-hour clock, CVSS, Originality, Incident, Government, Risk, OP, Original equipment manufacturer, SBOM, Artifact, DARPA, Engineering, Risk management

CHANTILLY, Va., Jan. 10, 2024 (GLOBE NEWSWIRE) -- OP[4] , a pioneer in the development of automated firmware security technologies for smart devices and industrial systems, announced today the launch of an advanced version of its groundbreaking product security platform.

Key Points: 
  • CHANTILLY, Va., Jan. 10, 2024 (GLOBE NEWSWIRE) -- OP[4] , a pioneer in the development of automated firmware security technologies for smart devices and industrial systems, announced today the launch of an advanced version of its groundbreaking product security platform.
  • “Historically, product security teams have only had the resources to perform limited, manual security assessments prior to a product release,” noted OP[4] CEO Irby Thompson.
  • The OP[4] Product Security Platform now enables OEMs and Integrators to perform automated and continuous security evaluations – providing real-time vulnerability insights, secure-by-design guidance, and cyber risk mitigations.”
    The platform, powered by OP[4]’s automated program analysis engine, originally developed under DARPA, continuously analyzes device firmware and detects N-day and 0-day vulnerabilities in compiled binary code in real time (without requiring source code).
  • Further, it helps product teams track security evolution build by build, and enables quality improvement visualization over time in fast-paced development cycles.

Fairfax Announces Pricing of Re-Opening of 6.000% Senior Notes Due 2033

Retrieved on: 
Tuesday, January 9, 2024
Debt-to-GDP ratio, Insurance, CUSIP, Annual report, Failure, Originality, Government, Fairfax Financial, EDGAR, Sale, Investment, TSX, Risk management, COVID-19, Regulation, Asbestos, FFH, United, Security (finance)

TORONTO, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that it has priced a private offering of an additional US$200,000,000 of its 6.000% Senior Notes due December 7, 2033 (the “Notes”) at an issue price of 100.998%, plus accrued interest.

Key Points: 
  • TORONTO, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that it has priced a private offering of an additional US$200,000,000 of its 6.000% Senior Notes due December 7, 2033 (the “Notes”) at an issue price of 100.998%, plus accrued interest.
  • Fairfax currently has outstanding US$400,000,000 aggregate principal amount of notes of this series (the “Original Notes”).
  • The Notes will have the same terms as the Original Notes, except for the issue date and the issue price, and will form part of the same series as the Original Notes, including with respect to interest payments.
  • The issue price for the Notes will include an aggregate amount of US$1,166,666.67 of accrued interest from December 7, 2023, the issue date of the Original Notes, to but excluding the settlement date of the Notes.

Automotive Transmission Dynamometer Market size in North America to grow by USD 565.05 million from 2023 to 2028; Future Scope and Innovations

Retrieved on: 
Thursday, January 11, 2024
College of Engineering (KNUST), Load testing, Challenge, Growth, Reciprocating engine, Automotive engineering, LINK, Gesellschaft mit beschränkter Haftung, Transmission, Originality, Innovation, Investment, Original equipment manufacturer, Development, PMM, Torque, NTS, Calibration, AVL, USD, Cost, Research, Instrumentation

The North America Automotive Transmission Dynamometer Market is driven by increased R&D investments due to cost pressures faced by automotive OEMs, spurred by compliance with environmental and safety standards.

Key Points: 
  • The North America Automotive Transmission Dynamometer Market is driven by increased R&D investments due to cost pressures faced by automotive OEMs, spurred by compliance with environmental and safety standards.
  • The automotive transmission dynamometer market in North America is fragmented owing to the presence of many global and regional companies.
  • Major Challenges - The North America Automotive Transmission Dynamometer Market confronts a notable challenge due to a shortage of skilled personnel adept in dynamometer testing, impacting Transmission Efficiency and Automotive Test Systems.
  • The automotive clutch actuator market size is estimated to grow by USD 7,601.28 million at a CAGR of 11.68% between 2023 and 2028.

The Laughing Cow® Launches Plant-Based Spreadable Cheese Alternative at Whole Foods

Retrieved on: 
Tuesday, January 9, 2024
Laughter, Originality, Kroger, Love, Cheese, GMO, The Laughing Cow, Whole Foods Market, Calcium, Dairy

CHICAGO, Jan. 9, 2024 /PRNewswire/ -- The Laughing Cow®, known for its spreadable, creamy cheese wedges, is starting off the new year on a plant-based note by launching its highly-anticipated dairy-free iteration, The Laughing Cow Plant-Based in Garlic & Herb, now on shelves at Whole Foods nationwide.

Key Points: 
  • CHICAGO, Jan. 9, 2024 /PRNewswire/ -- The Laughing Cow® , known for its spreadable, creamy cheese wedges, is starting off the new year on a plant-based note by launching its highly-anticipated dairy-free iteration, The Laughing Cow Plant-Based in Garlic & Herb, now on shelves at Whole Foods nationwide.
  • The vegan-certified cheese alternative comes in the same individually portioned wedges The Laughing Cow fans know and love.
  • Snackers can enjoy The Laughing Cow Plant-Based in endless combinations – like spread on a bagel, dipped with veggies, or scooped with crackers.
  • In addition to its fan-favorite creamy texture, The Laughing Cow Plant-Based is also a good source of calcium and is non-GMO certified.

Start your 2024 Wellness Journey with an Award-Winning Dandelion Coffee Alternative

Retrieved on: 
Monday, January 8, 2024
Coffee, Originality, Taste, Love, Crave, Caffeine, Vanilla

"We aim to fulfill the coffee experience with a full-bodied smell, taste, and feel, without the negative effects of caffeine.

Key Points: 
  • "We aim to fulfill the coffee experience with a full-bodied smell, taste, and feel, without the negative effects of caffeine.
  • The best part of our product is you can use it to make all your favourite drinks including espressos, lattes, and blended ice coffees.
  • They embarked on a journey to find the perfect alternative and were repeatedly disappointed because nothing satiated the way a freshly brewed cup of coffee did.
  • They were determined to create their own nutritious and crave-worthy alternative with the robust taste they loved so much.

Biscoff® Is Back at KRISPY KREME®!

Retrieved on: 
Monday, January 8, 2024
Retail, Other Consumer, Consumer, Restaurant, Bar, Other Retail, Specialty, Food, Beverage, Krispy Kreme, Six pack, Multimedia, Collection, Cookie butter, Chocolate, Love, Originality, Krispy, Speculoos, Baking

Krispy Kreme® is partnering again with Biscoff® to give guests even more of what they love: Krispy Kreme Biscoff doughnuts packed with more Biscoff in every bite.

Key Points: 
  • Krispy Kreme® is partnering again with Biscoff® to give guests even more of what they love: Krispy Kreme Biscoff doughnuts packed with more Biscoff in every bite.
  • Biscoff is back at Krispy Kreme!”
    The 2024 Biscoff collection includes:
    NEW Biscoff® Cookie Butter Cheesecake Doughnut: A shell doughnut filled with Biscoff® Cookie Butter cheesecake filling, dipped in Biscoff® Cookie Butter icing, topped with Biscoff® Cookie crumble and Biscoff® Cookie Butter drizzle.
  • NEW Biscoff® Chocolate Iced Cookie Butter Crunch Doughnut: An Original Glazed® doughnut dipped in chocolate icing topped with Biscoff® Cookie Butter buttercream dollop and Biscoff® Cookie crumble.
  • Biscoff® Cookie Butter Iced Doughnut: A Krispy Kreme Original Glazed® doughnut dipped in Biscoff® Cookie Butter icing.

Germany Defense Industry Report 2023-2028: Trends, Budgets, Regulations, Acquisitions, Competitive Landscape and Modernization Strategies - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 4, 2024
Other Defense, Defense, Policy, Future Combat Air System, NGF, Social Capital (venture capital), GDP, Original equipment manufacturer, Gross domestic product, Venture capital, Government, Growth, Originality, Competitive landscape, Arms industry

The "Germany Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Germany Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.
  • The report covers industry analysis including the key market drivers, emerging technology trends, and major challenges faced by market participants.
  • Germany defense budget: detailed analysis of Germany's 2023 defense budget broken down into market size and market share.
  • Competitive landscape and strategic insights: analysis of the competitive landscape of Germany's defense industry.

New Year, New Bright Energy® Beverages at The Human Bean

Retrieved on: 
Wednesday, January 3, 2024
Carnitine, The Human Bean, B12, Bright, Originality, Ice, Poolside, Energy, Watermelon, Blue Raspberry, Caffeine, Coffee

MEDFORD, Ore., Jan. 3, 2024 /PRNewswire/ -- A brand new, energizing blend is making a debut at The Human Bean drive thrus across the U.S.

Key Points: 
  • MEDFORD, Ore., Jan. 3, 2024 /PRNewswire/ -- A brand new, energizing blend is making a debut at The Human Bean drive thrus across the U.S.
  • The franchise is releasing its fresh and flavorful proprietary Bright Energy® energy drink — an innovative formula containing 160 mg. of caffeine and a special vitamin blend per 16 oz.
  • "We take such pride in the quality of our coffees, and this is a natural next step," says Dan Hawkins, co-founder and CEO of The Human Bean.
  • Thirsty customers in search of cool convenience and Bright flavor will find the new energy drinks at The Human Bean drive-thru locations starting January 3, 2024 and throughout the year.

Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 20/12/2021, Revision: 11, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024
People, Marketing, Immunodeficiency, INN, Risk, Sensation, Messenger, Nausea, RMP, Alpha, Myocarditis, Vaccination, Heart, Inflammation, Assessment, SARS, Fever, Anatomy, Paresthesia, IIA, Hypoesthesia, Skin, COVID-19 vaccine, Fatigue, ATC, Red, Pain, Ageing, Republic, Omicron, Allergy, Tenderness, Pregnancy, Safety, Medical Subject Headings, Group, Immune system, Antibody, EMA, International, Injection, Language, Select, Patient, Originality, Vomiting, Pericarditis, Anaphylaxis, System, Vaccine, Headache, Clinical trial, Swelling, Temperature, COVID-19, European Medicines Agency, SARS-CoV-2, Rash

Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 20/12/2021, Revision: 11, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 20/12/2021, Revision: 11, Status: Authorised